EichorEICHOR
Location: Barcelona Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Barcelona

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Hospital Universitari Vall d'Hebron · Pfizer · NCT05020236A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Hospital del Mar · AbbVie · NCT06602479KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Merck Sharp & Dohme LLC · NCT04165070International Leukemia Target Board
Phase N/A · Vall d'Hebron · Princess Maxima Center for Pediatric Oncology · NCT05270096Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Hospital Universitari Vall d'Hebron · Eli Lilly and Company · NCT07218380SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry
Phase N/A · Hospital Universitari Vall d'Hebron · Galaxy Therapeutics INC · NCT05880680Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Santa Creu and Sant Pau Hospital · Joseph Broderick, MD · NCT07227246Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Parc de Salut Mar - Hospital del Mar · Pfizer · NCT07028853Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · Hospital Universitari Vall d Hebron · Amgen · NCT04528082A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Hosp. Univ. Quiron Dexeus · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786Postoperative Pain in the Surgical Treatment of Hemorrhoids: Conventional Hemorrhoidectomy With a Monopolar Electric Sca
NA · Corporacion Parc Tauli · NCT06535269A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Hospital de La Santa Creu I San Pau · Takeda · NCT06747351Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · Hospital Sant Joan de Déu · CSL Behring · NCT07080905A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · Fundacio Puigvert · eleva GmbH · NCT07483827Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Vall D'hebron Institut De Recerca · Princess Maxima Center for Pediatric Oncology · NCT05327894A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · HOSPITAL CLÍNIC DE BARCELONA ( Site 1202) · Merck Sharp & Dohme LLC · NCT06136559Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Hospital Universitari Vall d'Hebron · Bristol-Myers Squibb · NCT07106762Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Hospital Universitari Vall d'Hebron-Oncology ( Site 2300) · Merck Sharp & Dohme LLC · NCT06393374Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital del Mar · Spanish Oncology Genito-Urinary Group · NCT06724159Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
Phase N/A · Hospital Clinic · M.D. Anderson Cancer Center · NCT03407469International Prospective REgistry on Pre-pectorAl Breast REconstruction
Phase N/A · Hospital del Mar · IRCCS San Raffaele · NCT05817175Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)
Phase 3 · Hospital Clinic De Barcelona · NTC srl · NCT07465705A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Hospital Universitari Vall d'Hebron ( Site 3402) · Merck Sharp & Dohme LLC · NCT07266831This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Hospital Universitari Dexeus · Pfizer · NCT06758401A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0115 · Bristol-Myers Squibb · NCT06929273Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Hospital Universitari Vall d'Hebron · Miltenyi Biomedicine GmbH · NCT04844866A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hem
Phase 3 · Institut Catala d'Oncologia · Regeneron Pharmaceuticals · NCT07154745
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.